Impact of the Extent of Circumferential Plaque on Nonculprit Lesion-Related Events: A PROSPECT Substudy

Kohei Koyama; Gary S. Mintz; Björn Redfors; Patrick W. Serruys; Bernard De Bruyne; David Erlinge; Gregg W. Stone; Akiko Maehara

doi:10.1016/j.jcmg.2019.03.008

Impact of the Extent of Circumferential Plaque on Nonculprit Lesion-Related Events: A PROSPECT Substudy

Kohei Koyama, Gary S. Mintz, Björn Redfors, Patrick W. Serruys, Bernard De Bruyne, David Erlinge, Gregg W. Stone, Akiko Maehara

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1883-1885
Number of pages	3
Journal	JACC: Cardiovascular Imaging
Volume	12
Issue number	9
DOIs	https://doi.org/10.1016/j.jcmg.2019.03.008
State	Published - Sep 2019

Access to Document

10.1016/j.jcmg.2019.03.008

Cite this

@article{bfbb3926d432423b88f6c4979a8795d5,

title = "Impact of the Extent of Circumferential Plaque on Nonculprit Lesion-Related Events: A PROSPECT Substudy",

author = "Kohei Koyama and Mintz, {Gary S.} and Bj{\"o}rn Redfors and Serruys, {Patrick W.} and {De Bruyne}, Bernard and David Erlinge and Stone, {Gregg W.} and Akiko Maehara",

note = "Funding Information: Please note: Dr. Koyama is on the advisory board of Goodman Medical and ASAHI INTECC. Dr. Mintz has received honoraria from Boston Scientific/Phillips. Dr. Serruys is a consultant for Abbott, Biosensors, Micell Technologies, Medtronic, SINOMED, Philips/Volcano, Xeltis, and HeartFlow. Dr. De Bruyne has received institutional grant support and consulting fees from Abbott, Biotronik, and Boston Scientific. Dr. Erlinge has received speaker fees from InfraReDx. Dr. Maehara has received institutional grant support from Boston Scientific and Abbott; is a consultant for Boston Scientific; and has received speaker fees from Abbott. Dr. Stone is a director of and holds equity in SpectraWAVE. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Funding Information: Please note: Dr. Koyama is on the advisory board of Goodman Medical and ASAHI INTECC. Dr. Mintz has received honoraria from Boston Scientific/Phillips. Dr. Serruys is a consultant for Abbott, Biosensors, Micell Technologies, Medtronic, SINOMED, Philips/Volcano, Xeltis, and HeartFlow. Dr. De Bruyne has received institutional grant support and consulting fees from Abbott, Biotronik, and Boston Scientific. Dr. Erlinge has received speaker fees from InfraReDx. Dr. Maehara has received institutional grant support from Boston Scientific and Abbott; is a consultant for Boston Scientific; and has received speaker fees from Abbott. Dr. Stone is a director of and holds equity in SpectraWAVE. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. ",

year = "2019",

month = sep,

doi = "10.1016/j.jcmg.2019.03.008",

language = "English",

volume = "12",

pages = "1883--1885",

journal = "JACC: Cardiovascular Imaging",

issn = "1936-878X",

publisher = "Elsevier Inc.",

number = "9",

}

TY - JOUR

T1 - Impact of the Extent of Circumferential Plaque on Nonculprit Lesion-Related Events

T2 - A PROSPECT Substudy

AU - Koyama, Kohei

AU - Mintz, Gary S.

AU - Redfors, Björn

AU - Serruys, Patrick W.

AU - De Bruyne, Bernard

AU - Erlinge, David

AU - Stone, Gregg W.

AU - Maehara, Akiko

N1 - Funding Information: Please note: Dr. Koyama is on the advisory board of Goodman Medical and ASAHI INTECC. Dr. Mintz has received honoraria from Boston Scientific/Phillips. Dr. Serruys is a consultant for Abbott, Biosensors, Micell Technologies, Medtronic, SINOMED, Philips/Volcano, Xeltis, and HeartFlow. Dr. De Bruyne has received institutional grant support and consulting fees from Abbott, Biotronik, and Boston Scientific. Dr. Erlinge has received speaker fees from InfraReDx. Dr. Maehara has received institutional grant support from Boston Scientific and Abbott; is a consultant for Boston Scientific; and has received speaker fees from Abbott. Dr. Stone is a director of and holds equity in SpectraWAVE. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Funding Information: Please note: Dr. Koyama is on the advisory board of Goodman Medical and ASAHI INTECC. Dr. Mintz has received honoraria from Boston Scientific/Phillips. Dr. Serruys is a consultant for Abbott, Biosensors, Micell Technologies, Medtronic, SINOMED, Philips/Volcano, Xeltis, and HeartFlow. Dr. De Bruyne has received institutional grant support and consulting fees from Abbott, Biotronik, and Boston Scientific. Dr. Erlinge has received speaker fees from InfraReDx. Dr. Maehara has received institutional grant support from Boston Scientific and Abbott; is a consultant for Boston Scientific; and has received speaker fees from Abbott. Dr. Stone is a director of and holds equity in SpectraWAVE. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

PY - 2019/9

Y1 - 2019/9

UR - http://www.scopus.com/inward/record.url?scp=85070983231&partnerID=8YFLogxK

U2 - 10.1016/j.jcmg.2019.03.008

DO - 10.1016/j.jcmg.2019.03.008

M3 - Letter

C2 - 31005536

AN - SCOPUS:85070983231

SN - 1936-878X

VL - 12

SP - 1883

EP - 1885

JO - JACC: Cardiovascular Imaging

JF - JACC: Cardiovascular Imaging

IS - 9

ER -